Anti‑cytokine therapy for psoriasis – not only TNF‑α blockers. Overview of reports on the effectiveness of therapy with IL‑12/IL‑23 and T and B lymphocyte inhibitors
TNF‑α inhibitors – infliximab, etanercept and adalimumab – can be used in the treatment of psoriasis vulgaris and psoriatic arthritis, along with other inhibitors of proinflammatory cytokines, such as interleukin‑12 (IL‑12) and IL‑23.This paper presents the results of research on the use of biologic...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Index Copernicus International S.A.
2016-12-01
|
Series: | Postępy Higieny i Medycyny Doświadczalnej |
Subjects: | |
Online Access: | http://phmd.pl/gicid/01.3001.0009.6898 |